CENTER CITY (WPVI) -- Jefferson University Hospital's Sidney Kimmel Cancer Center will begin tests soon on a new type of COVID-19 drug. It's based on disease-fighting T-cells, drawn from healthy ...

SAN FRANCISCO -- A new commercially available test called T-Detect has received emergency use authorization from the FDA. The manufacturer says it has the power to tell most patients whether or not ...

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causes a respiratory illness with systemic immune cell activation, inflammation, widespread multiorgan dysfunction, and thrombosis.

Scientists have identified molecular and structural changes in taste buds that may explain why a small subset of people experience long-term taste loss after COVID-19 infection.

Some individuals have experienced a loss of taste long after a COVID-19 infection has subsided. Researchers from the Swedish ...